Anticonvulsant activity and monoamine oxidase inhibitory properties of 1,3,5-trisubstituted pyrazolines.
D000098:Acetophenones / Q000138:chemical synthesis; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D001921:Brain / Q000201:enzymology; D007737:Kynurenine / Q000378:metabolism; D008297:Male; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors / Q000494:pharmacology; D011427:Propiophenones / Q000494:pharmacology; D011720:Pyrazoles / Q000032:analysis / Q000138:chemical synthesis / Q000494:pharmacology*; D051381:Rats; D012640:Seizures / Q000139:chemically induced; D013050:Spectrometry, Fluorescence
D000098:Acetophenones; D000927:Anticonvulsants; D008996:Monoamine Oxidase Inhibitors; D011427:Propiophenones; D011720:Pyrazoles; D007737:Kynurenine; D010433:Pentylenetetrazole